China Carbon Neutral Development Group (HKG:1372) signed a letter of intent to acquire China Agricultural Sea Rice (Shenzhen) Biotechnology, a biotech firm focused on salt-alkali-tolerant crops, according to a May 30 Hong Kong bourse filing.
The potential deal, pending due diligence and a final agreement, aims to boost CCNG's capabilities in saline-alkali land rehabilitation and carbon sink development.
CCNG said the acquisition would strengthen its position in carbon markets, green finance, and ESG, creating new growth opportunities.
Shares of the carbon solutions company slipped about 2% in recent trade on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.